Prostatis Group’s Vanguard Long-Term Bond ETF BLV Stock Holding History

Prostatis Group’s Portfolio BLV Stock Details BLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.61M	Sell	23,439 -2,976	-11%	-$208K	0.41%	59
2025 Q4	$1.84M	Buy	26,415 +133	+0.5%	+$9.41K	0.44%	50
2025 Q3	$1.86M	Sell	26,282 -373	-1%	-$25.9K	0.47%	52
2025 Q2	$1.85M	Sell	26,655 -2,824	-10%	-$193K	0.53%	49
2025 Q1	$2.08M	Buy	29,479 +3,350	+13%	+$233K	0.65%	40
2024 Q4	$1.79M	Buy	26,129 +2,096	+9%	+$150K	0.52%	43
2024 Q3	$1.81M	Sell	24,033 -3,758	-14%	-$276K	0.59%	44
2024 Q2	$1.95M	Sell	27,791 -159	-0.6%	-$11.1K	0.69%	44
2024 Q1	$2.02M	Sell	27,950 -57	-0.2%	-$4.11K	0.77%	37
2023 Q4	$2.09M	Sell	28,007 -2,114	-7%	-$145K	0.87%	34
2023 Q3	$2.02M	Buy	30,121 +3,372	+13%	+$240K	0.99%	20
2023 Q2	$2M	Buy	26,749 +772	+3%	+$58K	0.93%	27
2023 Q1	$1.96M	Sell	25,977 -865	-3%	-$65.4K	1.03%	26
2022 Q4	$1.94M	Sell	26,842 -74	-0.3%	-$5.36K	1.19%	27
2022 Q3	$1.94M	Buy	+26,916	New	+$2.13M	2.23%	16

Other funds holding BLV

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LNC

Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $14.1B AUM 25.71% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prostatis Group's BLV Position: Q1 2026 in Review

Prostatis Group reduced its Vanguard Long-Term Bond ETF (BLV) stake by 11% in Q1 2026, selling an estimated $208K and leaving 23,439 shares worth $1.61M. The position accounts for 0.41% of the portfolio, ranked #59.

Prostatis Group first reported a position in BLV in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.09M in Q4 2023. 407 funds tracked by Wall St. Rank hold BLV as of Q1 2026.

Prostatis Group held 23,439 shares of Vanguard Long-Term Bond ETF worth $1.61M as of Q1 2026.
Prostatis Group sold 2,976 Vanguard Long-Term Bond ETF shares in Q1 2026, an estimated $208K.
Vanguard Long-Term Bond ETF made up 0.41% of Prostatis Group's portfolio in Q1 2026, its #59 holding.
Prostatis Group first reported a position in Vanguard Long-Term Bond ETF in Q3 2022 and has held it in 15 quarters since.
Prostatis Group's Vanguard Long-Term Bond ETF position peaked at $2.09M in Q4 2023.
407 funds tracked by Wall St. Rank held Vanguard Long-Term Bond ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.